"Peste 24 de ani de experiență în servicii de gastroenterologie. Am început în anul 1994 ca o policlinică de interne și gastroenterologie cu o echipă medicală multidisciplinară. Astăzi serviciile noastre se adresează pacienților cu boli intestinale, policlinica Algomed Timișoara fiind un centru de excelență în domeniul gastroenterologiei."

During the past decade, Centrul de Gastroenterologie Dr. Goldis conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 18 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 14 clinical trials were completed. i.e. 466.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrul de Gastroenterologie Dr. Goldis" #1 sponsor was "Shire" with 10 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Takeda" with 4 trials sponsored, "Celgene" with 3 trials sponsored and "Galapagos NV" with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrul de Gastroenterologie Dr. Goldis" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centrul de Gastroenterologie Dr. Goldis" are "Ulcerative Colitis" (12 trials), "Crohn's Disease" (11 trials), "Crohn Disease" (4 trials), "Colitis, Ulcerative" (3 trials) and "Constipation" (1 trials). Many other conditions were trialed in "Centrul de Gastroenterologie Dr. Goldis" in a lesser frequency.

Most popular intervention types in "Centrul de Gastroenterologie Dr. Goldis" are "Drug" (31 trials), "Other" (7 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Etrolizumab" (4 trials), "Filgotinib" (4 trials), "Ontamalimab" (4 trials) and "GED-0301" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centrul de Gastroenterologie Dr. Goldis" are 31 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centrul de Gastroenterologie Dr. Goldis". undefined are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Centrul de Gastroenterologie Dr. Goldis, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Centrul de Gastroenterologie Dr. Goldis, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".